Nearshoring Opportunities for the Mexican Health Industry
Analysis
COVID-19 has sparked opportunities for already promising sectors of the Mexican economy.
MHR2018_Book_Ch8_Efren-Ocampo
View from the Top
Efrén Ocampo
President
Grupo Neolpharma
Grupo Neolpharma prepares to inaugurate a new injectables plant, while it studies the construction of a new facility for API production.
Efrén Ocampo President of Grupo Neolpharma
View from the Top
Efrén Ocampo
President
Grupo Neolpharma
Strategic investment has made Grupo Neolpharma an important partner for both the public and private sectors. Learn why.
MHS 2018
News Article
Mexico Health Summit 2018: Universal Healthcare: Are We There Yet? panel highlights
Efrén Ocampo
View from the Top
Efrén Ocampo
President
Grupo Neolpharma
Grupo Neolpharma is a Mexican pharmaceutical group that incorporates three companies: Psicofarma, Neolpharma and Alpharma.
Efrén Ocampo
Roundtable
Efrén Ocampo
Efrén Campo
President and Executive Director
Grupo Neolpharma

Biotechnology and nanotechnology are two lines in which we are interested in stimulating research. The prize (CINVESTAV’s prize for innovation in bionanotechnology) was linked to pharmacology but it is now more open as it has enabled the creation of new materials. The invitation to participate is open to all the institutions and professionals working on those themes and the prize is MX$300,000 (US$16,666). Half of the award is to reward the researcher and the other half is to fund the continuity of the winning project. The purpose of the prize is to create new talent, provide exposure and increase the diffusion of these kinds of scientific proposals. We are approaching 2016’s winning researcher to ask for his help capsulating some drugs we want to deliver to the limbic part of the brain.

MHR asked 7 leaders from companies working in the healthcare sector about their contributions to improving Mexican health talent.
Efren Ocampo
View from the Top
Efren Ocampo
President and Executive Director
Grupo Neolpharma
Grupo Neolpharma is a Mexican group that comprises several pharmaceutical companies
Efrén Ocampo
View from the Top
Efrén Ocampo
Director General
Grupo Neolpharma
Grupo Neolpharma’s growth rate slightly surpasses the market average.
Efrén Ocampo
View from the Top
Efrén Ocampo
Director General
Psicofarma
Psicofarma focuses on the private market for neuropsychiatry and is the most important company in the Neolpharma group.
Subscribe to Efrén Ocampo